|
| Jorge Cortes | H. Lee Moffitt Cancer Center and Research Institute, Washington University School of Medicine, The University of Texas MD Anderson Cancer Center, Oregon Health & Science University, University of Kansas Medical Center, Weill Cornell Medical College, University of Rochester, Medical University of South Carolina, Vanderbilt-Ingram Cancer Center, The Leukemia Program at Northside Hospital Cancer Center Institute, Dana-Farber Cancer Institute, University of Michigan, University of California-Los Angeles, University of California-San Diego, Jazz Pharmaceuticals, Stanford University School of Medicine |
| Laura F Newell | H. Lee Moffitt Cancer Center and Research Institute, Washington University School of Medicine, The University of Texas MD Anderson Cancer Center, Oregon Health & Science University, University of Kansas Medical Center, Weill Cornell Medical College, University of Rochester, Medical University of South Carolina, Vanderbilt-Ingram Cancer Center, The Leukemia Program at Northside Hospital Cancer Center Institute, Dana-Farber Cancer Institute, University of Michigan, University of California-Los Angeles, University of California-San Diego, Jazz Pharmaceuticals, Stanford University School of Medicine |
| Tara L Lin | H. Lee Moffitt Cancer Center and Research Institute, Washington University School of Medicine, The University of Texas MD Anderson Cancer Center, Oregon Health & Science University, University of Kansas Medical Center, Weill Cornell Medical College, University of Rochester, Medical University of South Carolina, Vanderbilt-Ingram Cancer Center, The Leukemia Program at Northside Hospital Cancer Center Institute, Dana-Farber Cancer Institute, University of Michigan, University of California-Los Angeles, University of California-San Diego, Jazz Pharmaceuticals, Stanford University School of Medicine |
| Richard M Stone | H. Lee Moffitt Cancer Center and Research Institute, Washington University School of Medicine, The University of Texas MD Anderson Cancer Center, Oregon Health & Science University, University of Kansas Medical Center, Weill Cornell Medical College, University of Rochester, Medical University of South Carolina, Vanderbilt-Ingram Cancer Center, The Leukemia Program at Northside Hospital Cancer Center Institute, Dana-Farber Cancer Institute, University of Michigan, University of California-Los Angeles, University of California-San Diego, Jazz Pharmaceuticals, Stanford University School of Medicine |
| John T Schiller | H. Lee Moffitt Cancer Center and Research Institute, Washington University School of Medicine, The University of Texas MD Anderson Cancer Center, Oregon Health & Science University, University of Kansas Medical Center, Weill Cornell Medical College, University of Rochester, Medical University of South Carolina, Vanderbilt-Ingram Cancer Center, The Leukemia Program at Northside Hospital Cancer Center Institute, Dana-Farber Cancer Institute, University of Michigan, University of California-Los Angeles, University of California-San Diego, Jazz Pharmaceuticals, Stanford University School of Medicine |
| Bruno C Medeiros | H. Lee Moffitt Cancer Center and Research Institute, Washington University School of Medicine, The University of Texas MD Anderson Cancer Center, Oregon Health & Science University, University of Kansas Medical Center, Weill Cornell Medical College, University of Rochester, Medical University of South Carolina, Vanderbilt-Ingram Cancer Center, The Leukemia Program at Northside Hospital Cancer Center Institute, Dana-Farber Cancer Institute, University of Michigan, University of California-Los Angeles, University of California-San Diego, Jazz Pharmaceuticals, Stanford University School of Medicine |